Scinai Immunotherapeutics ADR Logo
US09073Q4029
A42JHP

Scinai Immunotherapeutics ADR

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Scinai Immunotherapeutics ADR had revenue of €1.64M and net profit of -€1.74M
(EUR) September 2026
YoY
Revenue 1.64M 614.84%
Gross profit -530.59K 9.89%
Net profit -1.74M 2.33%
EBITDA -1.26M 3.30%

Fundamentals

Metric Value
Market capitalization
€196.1K
Number of shares
516.94K
52-week high/low
€11.81 - €0.35
Dividends No
Beta
2.27
P/E ratio
0.00
PEG ratio
0.00
P/B ratio
0.01
P/S ratio
0.07

Company profile

Name
Scinai Immunotherapeutics ADR
CEO
Amir Reichman
Employees 45
🍪

Parqet  uses cookies. Learn more